

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 6.37820007 |
| 2 | regulation of synapse structural plasticity (GO:0051823) | 6.05300267 |
| 3 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.86869509 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.67598037 |
| 5 | cell communication by electrical coupling (GO:0010644) | 5.56266454 |
| 6 | prepulse inhibition (GO:0060134) | 5.47753411 |
| 7 | locomotory exploration behavior (GO:0035641) | 5.47416905 |
| 8 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.44719023 |
| 9 | synaptic vesicle maturation (GO:0016188) | 5.38384134 |
| 10 | cardiac muscle contraction (GO:0060048) | 5.34306944 |
| 11 | synaptic transmission, dopaminergic (GO:0001963) | 5.31970644 |
| 12 | regulation of actin filament-based movement (GO:1903115) | 5.30358623 |
| 13 | cell communication involved in cardiac conduction (GO:0086065) | 5.23855474 |
| 14 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.21224581 |
| 15 | cardiac myofibril assembly (GO:0055003) | 5.00235694 |
| 16 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.94358599 |
| 17 | vocalization behavior (GO:0071625) | 4.93509118 |
| 18 | sarcomere organization (GO:0045214) | 4.87537367 |
| 19 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.83913963 |
| 20 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.82919372 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.81716144 |
| 22 | auditory behavior (GO:0031223) | 4.78986475 |
| 23 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.78582574 |
| 24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.78089405 |
| 25 | striatum development (GO:0021756) | 4.77213298 |
| 26 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.61613906 |
| 27 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.57692124 |
| 28 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.55192858 |
| 29 | detection of calcium ion (GO:0005513) | 4.53596676 |
| 30 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.51957263 |
| 31 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.45771603 |
| 32 | regulation of cell communication by electrical coupling (GO:0010649) | 4.45279669 |
| 33 | cardiac muscle hypertrophy (GO:0003300) | 4.41359761 |
| 34 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.36904059 |
| 35 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.36300779 |
| 36 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.35876025 |
| 37 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.35410712 |
| 38 | myofibril assembly (GO:0030239) | 4.33333565 |
| 39 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.29245112 |
| 40 | dendritic spine morphogenesis (GO:0060997) | 4.26102977 |
| 41 | synaptic vesicle exocytosis (GO:0016079) | 4.17808422 |
| 42 | striated muscle hypertrophy (GO:0014897) | 4.16932161 |
| 43 | response to amphetamine (GO:0001975) | 4.16218544 |
| 44 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.15569269 |
| 45 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.14878066 |
| 46 | response to auditory stimulus (GO:0010996) | 4.11970389 |
| 47 | sodium ion export (GO:0071436) | 4.04553288 |
| 48 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.04532190 |
| 49 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.04290524 |
| 50 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.01822663 |
| 51 | behavioral response to cocaine (GO:0048148) | 4.01691641 |
| 52 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.00974180 |
| 53 | regulation of the force of heart contraction (GO:0002026) | 3.99127497 |
| 54 | positive regulation of neurotransmitter transport (GO:0051590) | 3.98112706 |
| 55 | protein localization to synapse (GO:0035418) | 3.94668713 |
| 56 | cAMP catabolic process (GO:0006198) | 3.93427899 |
| 57 | exploration behavior (GO:0035640) | 3.88568716 |
| 58 | neuron-neuron synaptic transmission (GO:0007270) | 3.85704904 |
| 59 | neurotransmitter secretion (GO:0007269) | 3.84885359 |
| 60 | layer formation in cerebral cortex (GO:0021819) | 3.84558814 |
| 61 | long-term memory (GO:0007616) | 3.81872081 |
| 62 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.80556570 |
| 63 | * neuromuscular process controlling balance (GO:0050885) | 3.77367158 |
| 64 | cardiac chamber formation (GO:0003207) | 3.77264122 |
| 65 | actin-myosin filament sliding (GO:0033275) | 3.75840462 |
| 66 | muscle filament sliding (GO:0030049) | 3.75840462 |
| 67 | positive regulation of membrane potential (GO:0045838) | 3.75664629 |
| 68 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.75627558 |
| 69 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.75627558 |
| 70 | regulation of female receptivity (GO:0045924) | 3.75553315 |
| 71 | neuronal action potential propagation (GO:0019227) | 3.75063586 |
| 72 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.72409385 |
| 73 | striated muscle contraction (GO:0006941) | 3.71656406 |
| 74 | transmission of nerve impulse (GO:0019226) | 3.70603520 |
| 75 | regulation of relaxation of muscle (GO:1901077) | 3.70288035 |
| 76 | neuronal ion channel clustering (GO:0045161) | 3.70144750 |
| 77 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.69594324 |
| 78 | muscle hypertrophy (GO:0014896) | 3.69418200 |
| 79 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.67616774 |
| 80 | synaptic transmission, glutamatergic (GO:0035249) | 3.66498338 |
| 81 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.65370187 |
| 82 | regulation of heart rate (GO:0002027) | 3.62575963 |
| 83 | cellular response to epinephrine stimulus (GO:0071872) | 3.62183516 |
| 84 | gamma-aminobutyric acid transport (GO:0015812) | 3.61752063 |
| 85 | regulation of glutamate secretion (GO:0014048) | 3.60010184 |
| 86 | cardiac ventricle formation (GO:0003211) | 3.59932926 |
| 87 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.59538114 |
| 88 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.58460858 |
| 89 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.58460858 |
| 90 | regulation of synaptic vesicle transport (GO:1902803) | 3.57303668 |
| 91 | cardiac conduction (GO:0061337) | 3.57258621 |
| 92 | adult heart development (GO:0007512) | 3.55452524 |
| 93 | glycine transport (GO:0015816) | 3.54236507 |
| 94 | cyclic nucleotide catabolic process (GO:0009214) | 3.52989378 |
| 95 | regulation of postsynaptic membrane potential (GO:0060078) | 3.51968695 |
| 96 | mechanosensory behavior (GO:0007638) | 3.50243389 |
| 97 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.50030808 |
| 98 | regulation of striated muscle contraction (GO:0006942) | 3.49589132 |
| 99 | * dopamine receptor signaling pathway (GO:0007212) | 3.49477035 |
| 100 | cardiac muscle cell action potential (GO:0086001) | 3.48811646 |
| 101 | regulation of synaptic plasticity (GO:0048167) | 3.45714188 |
| 102 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.43995961 |
| 103 | muscle hypertrophy in response to stress (GO:0003299) | 3.43995961 |
| 104 | cardiac muscle adaptation (GO:0014887) | 3.43995961 |
| 105 | glutamate receptor signaling pathway (GO:0007215) | 3.43961808 |
| 106 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.43826956 |
| 107 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.43594539 |
| 108 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.43553674 |
| 109 | membrane hyperpolarization (GO:0060081) | 3.43125768 |
| 110 | glutamate secretion (GO:0014047) | 3.42529667 |
| 111 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.41533054 |
| 112 | regulation of neurotransmitter uptake (GO:0051580) | 3.40167151 |
| 113 | regulation of protein kinase A signaling (GO:0010738) | 3.39762303 |
| 114 | visual learning (GO:0008542) | 3.39605923 |
| 115 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.37714605 |
| 116 | neuron cell-cell adhesion (GO:0007158) | 3.33578241 |
| 117 | regulation of dendritic spine development (GO:0060998) | 3.33149089 |
| 118 | regulation of cardiac muscle contraction (GO:0055117) | 3.30876760 |
| 119 | actomyosin structure organization (GO:0031032) | 3.30787496 |
| 120 | cardiac muscle cell development (GO:0055013) | 3.30485324 |
| 121 | female mating behavior (GO:0060180) | 3.30220342 |
| 122 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.29197966 |
| 123 | cellular response to catecholamine stimulus (GO:0071870) | 3.28907126 |
| 124 | cellular response to monoamine stimulus (GO:0071868) | 3.28907126 |
| 125 | relaxation of cardiac muscle (GO:0055119) | 3.27367668 |
| 126 | peristalsis (GO:0030432) | 3.26235598 |
| 127 | regulation of heart contraction (GO:0008016) | 3.25688158 |
| 128 | response to epinephrine (GO:0071871) | 3.25285670 |
| 129 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.25280595 |
| 130 | mating behavior (GO:0007617) | 3.24052908 |
| 131 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.23201041 |
| 132 | regulation of cardioblast differentiation (GO:0051890) | 3.22037205 |
| 133 | behavioral fear response (GO:0001662) | 3.21736443 |
| 134 | behavioral defense response (GO:0002209) | 3.21736443 |
| 135 | visual behavior (GO:0007632) | 3.19571092 |
| 136 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.17960078 |
| 137 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.16962394 |
| 138 | response to histamine (GO:0034776) | 3.13800127 |
| 139 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.13345080 |
| 140 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.13345080 |
| 141 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.11951844 |
| 142 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.11307271 |
| 143 | negative regulation of dendrite development (GO:2000171) | 3.10926789 |
| 144 | membrane depolarization during action potential (GO:0086010) | 3.10382106 |
| 145 | membrane depolarization (GO:0051899) | 3.10363215 |
| 146 | positive regulation of sodium ion transport (GO:0010765) | 3.09855115 |
| 147 | long-term synaptic potentiation (GO:0060291) | 3.09198774 |
| 148 | cardiac cell development (GO:0055006) | 3.08961313 |
| 149 | learning (GO:0007612) | 3.08409034 |
| 150 | cellular potassium ion homeostasis (GO:0030007) | 3.07096118 |
| 151 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.06383454 |
| 152 | actin-mediated cell contraction (GO:0070252) | 3.05499013 |
| 153 | muscle tissue morphogenesis (GO:0060415) | 3.02311635 |
| 154 | negative regulation of amino acid transport (GO:0051956) | 3.02297073 |
| 155 | adrenergic receptor signaling pathway (GO:0071875) | 3.02050578 |
| 156 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.01308474 |
| 157 | * activation of protein kinase A activity (GO:0034199) | 3.00847648 |
| 158 | positive regulation of synaptic transmission (GO:0050806) | 3.00092973 |
| 159 | positive regulation of dendritic spine development (GO:0060999) | 2.99973543 |
| 160 | neurotransmitter transport (GO:0006836) | 2.99738592 |
| 161 | regulation of membrane repolarization (GO:0060306) | 2.99406619 |
| 162 | regulation of neurotransmitter levels (GO:0001505) | 2.98754379 |
| 163 | response to monoamine (GO:0071867) | 2.97667596 |
| 164 | response to catecholamine (GO:0071869) | 2.97667596 |
| 165 | neuromuscular process controlling posture (GO:0050884) | 2.97542389 |
| 166 | adult walking behavior (GO:0007628) | 2.97468954 |
| 167 | regulation of neurotransmitter transport (GO:0051588) | 2.97073310 |
| 168 | cellular sodium ion homeostasis (GO:0006883) | 2.93873899 |
| 169 | L-amino acid import (GO:0043092) | 2.87057868 |
| 170 | multicellular organismal signaling (GO:0035637) | 2.85486153 |
| 171 | positive regulation of synapse maturation (GO:0090129) | 2.83986115 |
| 172 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.83104971 |
| 173 | NADH metabolic process (GO:0006734) | 2.80499046 |
| 174 | positive regulation of action potential (GO:0045760) | 2.79581583 |
| 175 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.77174933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.07253729 |
| 2 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.64946284 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12530851 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.07584841 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.92377209 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.91269884 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.84166093 |
| 8 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.80572121 |
| 9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.75036322 |
| 10 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.75036322 |
| 11 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.65377902 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.59106786 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.57261883 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56532554 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.53304138 |
| 16 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.53196560 |
| 17 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.44049449 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.34857009 |
| 19 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28220982 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.27535562 |
| 21 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.26079318 |
| 22 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15166496 |
| 23 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.12860847 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.09844712 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.04286651 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.01515737 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00457565 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.88381861 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.87704676 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70041770 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.66541859 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.52381803 |
| 33 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.51663606 |
| 34 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.49322785 |
| 35 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.49322785 |
| 36 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.48421025 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.47945218 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.46498930 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.43295993 |
| 40 | KDM2B_26808549_Chip-Seq_K562_Human | 1.42453111 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.38866436 |
| 42 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.38561278 |
| 43 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.38098577 |
| 44 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.33848736 |
| 45 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33026494 |
| 46 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31480445 |
| 47 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.30773110 |
| 48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29805653 |
| 49 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.28316982 |
| 50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.28246277 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26172449 |
| 52 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.26034663 |
| 53 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25664453 |
| 54 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.25468195 |
| 55 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25024514 |
| 56 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.24221660 |
| 57 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.23877183 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22908753 |
| 59 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22850626 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22762373 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.22161153 |
| 62 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21029171 |
| 63 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.20111216 |
| 64 | * AR_19668381_ChIP-Seq_PC3_Human | 1.17465027 |
| 65 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.16772197 |
| 66 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.16027074 |
| 67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15485753 |
| 68 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14120401 |
| 69 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11908334 |
| 70 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.11334958 |
| 71 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11262068 |
| 72 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11235077 |
| 73 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10653515 |
| 74 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.09288582 |
| 75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.09043248 |
| 76 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.09021087 |
| 77 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08933929 |
| 78 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08171643 |
| 79 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07437054 |
| 80 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05491178 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05082485 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.03987104 |
| 83 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99035177 |
| 84 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98982211 |
| 85 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98948120 |
| 86 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98329650 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98209397 |
| 88 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97960044 |
| 89 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97387217 |
| 90 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.96921938 |
| 91 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.96412893 |
| 92 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.95121579 |
| 93 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.94946752 |
| 94 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94776385 |
| 95 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.94425527 |
| 96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94314069 |
| 97 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93124978 |
| 98 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92986353 |
| 99 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.92984236 |
| 100 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.92963055 |
| 101 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.92796639 |
| 102 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91753309 |
| 103 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91092456 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90874793 |
| 105 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90039453 |
| 106 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88383479 |
| 107 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.87887689 |
| 108 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87626069 |
| 109 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87461258 |
| 110 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87385882 |
| 111 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86725404 |
| 112 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86642690 |
| 113 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85812494 |
| 114 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.85568295 |
| 115 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.85420033 |
| 116 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.85204429 |
| 117 | TP53_16413492_ChIP-PET_HCT116_Human | 0.84573805 |
| 118 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.84290256 |
| 119 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.83663316 |
| 120 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83256341 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83127309 |
| 122 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.82872687 |
| 123 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82284326 |
| 124 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81263683 |
| 125 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.81017921 |
| 126 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.78153965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 7.98491171 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 6.18607808 |
| 3 | MP0003880_abnormal_central_pattern | 4.02959491 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.97657052 |
| 5 | * MP0009745_abnormal_behavioral_response | 3.45030327 |
| 6 | MP0004270_analgesia | 3.33217243 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.30798009 |
| 8 | MP0002064_seizures | 2.94636586 |
| 9 | MP0009046_muscle_twitch | 2.76619817 |
| 10 | MP0005670_abnormal_white_adipose | 2.75532938 |
| 11 | MP0001486_abnormal_startle_reflex | 2.72669536 |
| 12 | MP0001529_abnormal_vocalization | 2.70588000 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.66930182 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.53638507 |
| 15 | MP0002272_abnormal_nervous_system | 2.48658266 |
| 16 | MP0002909_abnormal_adrenal_gland | 2.44192521 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.34373541 |
| 18 | MP0004510_myositis | 2.31742298 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.10417441 |
| 20 | MP0006138_congestive_heart_failure | 2.08303600 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.06512937 |
| 22 | MP0008775_abnormal_heart_ventricle | 2.05358875 |
| 23 | MP0005646_abnormal_pituitary_gland | 2.00938728 |
| 24 | MP0004924_abnormal_behavior | 1.96875061 |
| 25 | MP0005386_behavior/neurological_phenoty | 1.96875061 |
| 26 | MP0001544_abnormal_cardiovascular_syste | 1.82297328 |
| 27 | MP0005385_cardiovascular_system_phenoty | 1.82297328 |
| 28 | MP0004484_altered_response_of | 1.80990284 |
| 29 | MP0008569_lethality_at_weaning | 1.78343201 |
| 30 | MP0001970_abnormal_pain_threshold | 1.76161535 |
| 31 | MP0005409_darkened_coat_color | 1.72865588 |
| 32 | MP0000749_muscle_degeneration | 1.72689248 |
| 33 | MP0010630_abnormal_cardiac_muscle | 1.70976422 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.69909803 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.66187961 |
| 36 | MP0004811_abnormal_neuron_physiology | 1.62488273 |
| 37 | MP0002557_abnormal_social/conspecific_i | 1.57509832 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.55015548 |
| 39 | MP0002736_abnormal_nociception_after | 1.50916056 |
| 40 | MP0004885_abnormal_endolymph | 1.46906502 |
| 41 | MP0003329_amyloid_beta_deposits | 1.46877072 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.46843496 |
| 43 | MP0000751_myopathy | 1.44785927 |
| 44 | MP0001984_abnormal_olfaction | 1.43809293 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.40497206 |
| 46 | MP0005666_abnormal_adipose_tissue | 1.38192372 |
| 47 | MP0003075_altered_response_to | 1.36828117 |
| 48 | MP0003633_abnormal_nervous_system | 1.36540474 |
| 49 | MP0003879_abnormal_hair_cell | 1.31911253 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.29325468 |
| 51 | MP0003690_abnormal_glial_cell | 1.29016869 |
| 52 | * MP0002066_abnormal_motor_capabilities/c | 1.28506773 |
| 53 | MP0008874_decreased_physiological_sensi | 1.27579638 |
| 54 | MP0001177_atelectasis | 1.27454050 |
| 55 | MP0000955_abnormal_spinal_cord | 1.25324772 |
| 56 | MP0002735_abnormal_chemical_nociception | 1.25072272 |
| 57 | MP0001905_abnormal_dopamine_level | 1.24238364 |
| 58 | MP0004085_abnormal_heartbeat | 1.24217268 |
| 59 | MP0002184_abnormal_innervation | 1.23119000 |
| 60 | MP0002127_abnormal_cardiovascular_syste | 1.21911859 |
| 61 | MP0001188_hyperpigmentation | 1.20946066 |
| 62 | MP0002106_abnormal_muscle_physiology | 1.18398540 |
| 63 | MP0000920_abnormal_myelination | 1.17052999 |
| 64 | MP0008872_abnormal_physiological_respon | 1.16710862 |
| 65 | MP0004858_abnormal_nervous_system | 1.16342295 |
| 66 | MP0000778_abnormal_nervous_system | 1.15714225 |
| 67 | MP0002882_abnormal_neuron_morphology | 1.15314743 |
| 68 | MP0002269_muscular_atrophy | 1.13279521 |
| 69 | MP0003283_abnormal_digestive_organ | 1.09671861 |
| 70 | MP0003137_abnormal_impulse_conducting | 1.09073407 |
| 71 | MP0002638_abnormal_pupillary_reflex | 1.06503462 |
| 72 | MP0003631_nervous_system_phenotype | 1.06317168 |
| 73 | MP0008961_abnormal_basal_metabolism | 1.02392156 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.01910708 |
| 75 | MP0005369_muscle_phenotype | 1.01723222 |
| 76 | MP0005375_adipose_tissue_phenotype | 1.00957153 |
| 77 | MP0005535_abnormal_body_temperature | 0.97248488 |
| 78 | MP0000750_abnormal_muscle_regeneration | 0.96812875 |
| 79 | MP0002090_abnormal_vision | 0.96697831 |
| 80 | MP0001502_abnormal_circadian_rhythm | 0.94428527 |
| 81 | MP0004142_abnormal_muscle_tone | 0.92932026 |
| 82 | MP0004215_abnormal_myocardial_fiber | 0.91460359 |
| 83 | MP0002069_abnormal_eating/drinking_beha | 0.91239806 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 0.90969574 |
| 85 | MP0000759_abnormal_skeletal_muscle | 0.89880940 |
| 86 | MP0002152_abnormal_brain_morphology | 0.89305893 |
| 87 | MP0005165_increased_susceptibility_to | 0.86999911 |
| 88 | MP0004036_abnormal_muscle_relaxation | 0.85721290 |
| 89 | MP0003634_abnormal_glial_cell | 0.83167305 |
| 90 | MP0002229_neurodegeneration | 0.81723730 |
| 91 | MP0004130_abnormal_muscle_cell | 0.81681401 |
| 92 | MP0002971_abnormal_brown_adipose | 0.80525112 |
| 93 | MP0010234_abnormal_vibrissa_follicle | 0.77050377 |
| 94 | MP0000569_abnormal_digit_pigmentation | 0.76729341 |
| 95 | MP0003828_pulmonary_edema | 0.75587278 |
| 96 | MP0010368_abnormal_lymphatic_system | 0.74128807 |
| 97 | MP0005620_abnormal_muscle_contractility | 0.73268176 |
| 98 | MP0003787_abnormal_imprinting | 0.72166018 |
| 99 | MP0003646_muscle_fatigue | 0.71289331 |
| 100 | MP0006276_abnormal_autonomic_nervous | 0.70577843 |
| 101 | MP0000003_abnormal_adipose_tissue | 0.70086422 |
| 102 | MP0004043_abnormal_pH_regulation | 0.65697492 |
| 103 | MP0000631_abnormal_neuroendocrine_gland | 0.63840628 |
| 104 | MP0004145_abnormal_muscle_electrophysio | 0.63553270 |
| 105 | MP0001485_abnormal_pinna_reflex | 0.62346306 |
| 106 | MP0000604_amyloidosis | 0.61863271 |
| 107 | MP0005551_abnormal_eye_electrophysiolog | 0.61624597 |
| 108 | MP0003279_aneurysm | 0.61443833 |
| 109 | MP0003122_maternal_imprinting | 0.61015855 |
| 110 | MP0003632_abnormal_nervous_system | 0.60566575 |
| 111 | MP0002108_abnormal_muscle_morphology | 0.58043638 |
| 112 | MP0004742_abnormal_vestibular_system | 0.57788015 |
| 113 | MP0005394_taste/olfaction_phenotype | 0.57721177 |
| 114 | MP0005499_abnormal_olfactory_system | 0.57721177 |
| 115 | MP0000462_abnormal_digestive_system | 0.57297813 |
| 116 | MP0000266_abnormal_heart_morphology | 0.57033331 |
| 117 | MP0002234_abnormal_pharynx_morphology | 0.57021305 |
| 118 | MP0002295_abnormal_pulmonary_circulatio | 0.56953109 |
| 119 | MP0004233_abnormal_muscle_weight | 0.56736564 |
| 120 | MP0001664_abnormal_digestion | 0.56531707 |
| 121 | MP0005623_abnormal_meninges_morphology | 0.54740030 |
| 122 | MP0000747_muscle_weakness | 0.54424987 |
| 123 | MP0004084_abnormal_cardiac_muscle | 0.52413444 |
| 124 | MP0005330_cardiomyopathy | 0.50731885 |
| 125 | MP0005166_decreased_susceptibility_to | 0.49796459 |
| 126 | MP0004087_abnormal_muscle_fiber | 0.49202379 |
| 127 | MP0002972_abnormal_cardiac_muscle | 0.48816411 |
| 128 | MP0001943_abnormal_respiration | 0.48647379 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.47863475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.14253789 |
| 2 | * Myokymia (HP:0002411) | 6.74407623 |
| 3 | Focal seizures (HP:0007359) | 5.41406590 |
| 4 | Ventricular tachycardia (HP:0004756) | 5.36307075 |
| 5 | Hyporeflexia of lower limbs (HP:0002600) | 4.90971955 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 4.38049531 |
| 7 | Lipoatrophy (HP:0100578) | 4.37020105 |
| 8 | Ventricular arrhythmia (HP:0004308) | 4.32839122 |
| 9 | Torticollis (HP:0000473) | 4.31065903 |
| 10 | Action tremor (HP:0002345) | 4.20579184 |
| 11 | Ankle clonus (HP:0011448) | 4.13327411 |
| 12 | Muscle fiber splitting (HP:0003555) | 4.11814827 |
| 13 | Visual hallucinations (HP:0002367) | 4.06472517 |
| 14 | Poor eye contact (HP:0000817) | 4.03615773 |
| 15 | Annular pancreas (HP:0001734) | 3.80513727 |
| 16 | Abnormal social behavior (HP:0012433) | 3.69691092 |
| 17 | Impaired social interactions (HP:0000735) | 3.69691092 |
| 18 | Focal dystonia (HP:0004373) | 3.65984159 |
| 19 | Depression (HP:0000716) | 3.61799364 |
| 20 | Craniofacial dystonia (HP:0012179) | 3.60131589 |
| 21 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.59043252 |
| 22 | Prolonged QT interval (HP:0001657) | 3.56240478 |
| 23 | Broad-based gait (HP:0002136) | 3.53169415 |
| 24 | Abnormality of the calf musculature (HP:0001430) | 3.47169594 |
| 25 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.46610145 |
| 26 | Subaortic stenosis (HP:0001682) | 3.46610145 |
| 27 | Dysdiadochokinesis (HP:0002075) | 3.45792374 |
| 28 | * Dilated cardiomyopathy (HP:0001644) | 3.42622063 |
| 29 | Epileptic encephalopathy (HP:0200134) | 3.40854007 |
| 30 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.38703610 |
| 31 | Generalized tonic-clonic seizures (HP:0002069) | 3.33766477 |
| 32 | EMG: neuropathic changes (HP:0003445) | 3.31606212 |
| 33 | Papilledema (HP:0001085) | 3.18967206 |
| 34 | Urinary urgency (HP:0000012) | 3.15197779 |
| 35 | * Anxiety (HP:0000739) | 3.15123998 |
| 36 | Asymmetric septal hypertrophy (HP:0001670) | 3.14699510 |
| 37 | Dysmetria (HP:0001310) | 3.14353407 |
| 38 | Gaze-evoked nystagmus (HP:0000640) | 3.12799055 |
| 39 | Ankyloglossia (HP:0010296) | 3.12739161 |
| 40 | Supranuclear gaze palsy (HP:0000605) | 3.11143161 |
| 41 | Postural instability (HP:0002172) | 3.09370521 |
| 42 | Abnormal EKG (HP:0003115) | 3.07420855 |
| 43 | Febrile seizures (HP:0002373) | 3.06866261 |
| 44 | Absence seizures (HP:0002121) | 3.06162044 |
| 45 | Lower limb amyotrophy (HP:0007210) | 3.04309673 |
| 46 | Atrioventricular block (HP:0001678) | 3.02714450 |
| 47 | Scanning speech (HP:0002168) | 3.00983857 |
| 48 | Dysmetric saccades (HP:0000641) | 2.99229014 |
| 49 | Distal lower limb muscle weakness (HP:0009053) | 2.97317648 |
| 50 | Ventricular fibrillation (HP:0001663) | 2.89966941 |
| 51 | Intention tremor (HP:0002080) | 2.88404080 |
| 52 | Dialeptic seizures (HP:0011146) | 2.88039526 |
| 53 | EMG: myopathic abnormalities (HP:0003458) | 2.86408629 |
| 54 | Spastic gait (HP:0002064) | 2.85552603 |
| 55 | Abnormality of the foot musculature (HP:0001436) | 2.84469212 |
| 56 | Truncal ataxia (HP:0002078) | 2.84113438 |
| 57 | Pointed chin (HP:0000307) | 2.82554928 |
| 58 | Left ventricular hypertrophy (HP:0001712) | 2.82036932 |
| 59 | Stereotypic behavior (HP:0000733) | 2.81752339 |
| 60 | Atonic seizures (HP:0010819) | 2.78069407 |
| 61 | Progressive cerebellar ataxia (HP:0002073) | 2.77820409 |
| 62 | Abnormal eating behavior (HP:0100738) | 2.77184307 |
| 63 | Heart block (HP:0012722) | 2.70938573 |
| 64 | Bundle branch block (HP:0011710) | 2.64372698 |
| 65 | Foot dorsiflexor weakness (HP:0009027) | 2.58637433 |
| 66 | Megalencephaly (HP:0001355) | 2.57107383 |
| 67 | Atrial fibrillation (HP:0005110) | 2.56887602 |
| 68 | Neurofibrillary tangles (HP:0002185) | 2.55428947 |
| 69 | Sudden death (HP:0001699) | 2.54167525 |
| 70 | Limb dystonia (HP:0002451) | 2.54047645 |
| 71 | Primary atrial arrhythmia (HP:0001692) | 2.53418934 |
| 72 | Palpitations (HP:0001962) | 2.51819225 |
| 73 | Polygenic inheritance (HP:0010982) | 2.51432751 |
| 74 | Mutism (HP:0002300) | 2.51362335 |
| 75 | Bradycardia (HP:0001662) | 2.47895810 |
| 76 | Abnormal atrioventricular conduction (HP:0005150) | 2.46014616 |
| 77 | Difficulty running (HP:0009046) | 2.44378693 |
| 78 | Calf muscle hypertrophy (HP:0008981) | 2.43795934 |
| 79 | Impaired vibratory sensation (HP:0002495) | 2.43182049 |
| 80 | Lower limb muscle weakness (HP:0007340) | 2.42432787 |
| 81 | Bradykinesia (HP:0002067) | 2.41971057 |
| 82 | Clonus (HP:0002169) | 2.41016912 |
| 83 | Impaired smooth pursuit (HP:0007772) | 2.38629702 |
| 84 | Supraventricular tachycardia (HP:0004755) | 2.37525599 |
| 85 | Hypoplastic left heart (HP:0004383) | 2.37458976 |
| 86 | Termporal pattern (HP:0011008) | 2.35640282 |
| 87 | Insidious onset (HP:0003587) | 2.35640282 |
| 88 | Distal lower limb amyotrophy (HP:0008944) | 2.31858904 |
| 89 | Abnormality of oral frenula (HP:0000190) | 2.31849121 |
| 90 | Supraventricular arrhythmia (HP:0005115) | 2.30842428 |
| 91 | Abnormality of the lower motor neuron (HP:0002366) | 2.29668285 |
| 92 | Sudden cardiac death (HP:0001645) | 2.28251369 |
| 93 | Cerebral inclusion bodies (HP:0100314) | 2.27160241 |
| 94 | Hemiplegia (HP:0002301) | 2.25206990 |
| 95 | Progressive inability to walk (HP:0002505) | 2.23307402 |
| 96 | Distal upper limb amyotrophy (HP:0007149) | 2.22001951 |
| 97 | Upper limb amyotrophy (HP:0009129) | 2.22001951 |
| 98 | Incomplete penetrance (HP:0003829) | 2.17349527 |
| 99 | Onion bulb formation (HP:0003383) | 2.17013695 |
| 100 | Hemiparesis (HP:0001269) | 2.14974628 |
| 101 | Amblyopia (HP:0000646) | 2.11268909 |
| 102 | Abnormality of binocular vision (HP:0011514) | 2.10627062 |
| 103 | Diplopia (HP:0000651) | 2.10627062 |
| 104 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.10426285 |
| 105 | Pheochromocytoma (HP:0002666) | 2.09681032 |
| 106 | Increased variability in muscle fiber diameter (HP:0003557) | 2.09372764 |
| 107 | Syncope (HP:0001279) | 2.07684402 |
| 108 | Hyperventilation (HP:0002883) | 2.06311488 |
| 109 | Exercise-induced myalgia (HP:0003738) | 2.05324943 |
| 110 | Congenital malformation of the right heart (HP:0011723) | 2.03972095 |
| 111 | Double outlet right ventricle (HP:0001719) | 2.03972095 |
| 112 | Neuronal loss in central nervous system (HP:0002529) | 2.03073052 |
| 113 | Abnormality of the corticospinal tract (HP:0002492) | 2.02998956 |
| 114 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.01284657 |
| 115 | Abnormality of saccadic eye movements (HP:0000570) | 2.00764144 |
| 116 | Insomnia (HP:0100785) | 2.00023667 |
| 117 | Obstructive sleep apnea (HP:0002870) | 1.99870481 |
| 118 | Abnormality of the periventricular white matter (HP:0002518) | 1.99612807 |
| 119 | Truncus arteriosus (HP:0001660) | 1.99314300 |
| 120 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.98004521 |
| 121 | Axonal loss (HP:0003447) | 1.97528752 |
| 122 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.97263451 |
| 123 | Aplasia of the phalanges of the hand (HP:0009802) | 1.97263451 |
| 124 | Aplasia involving bones of the extremities (HP:0009825) | 1.97263451 |
| 125 | Steppage gait (HP:0003376) | 1.94165558 |
| 126 | Genetic anticipation (HP:0003743) | 1.93728639 |
| 127 | Bowel incontinence (HP:0002607) | 1.93668595 |
| 128 | Lymphangioma (HP:0100764) | 1.91816574 |
| 129 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.91391792 |
| 130 | Status epilepticus (HP:0002133) | 1.91276119 |
| 131 | Lower limb asymmetry (HP:0100559) | 1.89903031 |
| 132 | Neck muscle weakness (HP:0000467) | 1.87917772 |
| 133 | Drooling (HP:0002307) | 1.87171267 |
| 134 | Ragged-red muscle fibers (HP:0003200) | 1.86951392 |
| 135 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.83975968 |
| 136 | Myotonia (HP:0002486) | 1.83261704 |
| 137 | Hypoplastic heart (HP:0001961) | 1.79091333 |
| 138 | Type 1 muscle fiber predominance (HP:0003803) | 1.76878946 |
| 139 | Rapidly progressive (HP:0003678) | 1.75603253 |
| 140 | Slow progression (HP:0003677) | 1.73674005 |
| 141 | Frequent falls (HP:0002359) | 1.73334360 |
| 142 | Palmoplantar keratoderma (HP:0000982) | 1.71694257 |
| 143 | Polyphagia (HP:0002591) | 1.68197572 |
| 144 | Hypercortisolism (HP:0001578) | 1.67604903 |
| 145 | Skin nodule (HP:0200036) | 1.66829375 |
| 146 | Scapular winging (HP:0003691) | 1.66027534 |
| 147 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.65250477 |
| 148 | Tetraplegia (HP:0002445) | 1.64442054 |
| 149 | Turricephaly (HP:0000262) | 1.63389318 |
| 150 | Sleep apnea (HP:0010535) | 1.62819795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 7.18325199 |
| 2 | NTRK3 | 3.82493457 |
| 3 | MYLK | 3.65632982 |
| 4 | MAP3K9 | 3.45629171 |
| 5 | KSR2 | 2.74179306 |
| 6 | PRKD3 | 2.73024058 |
| 7 | DAPK2 | 2.70506537 |
| 8 | TTN | 2.40866134 |
| 9 | CAMKK1 | 2.22985544 |
| 10 | RIPK4 | 2.21860539 |
| 11 | NTRK1 | 2.15526444 |
| 12 | MINK1 | 2.12441435 |
| 13 | MARK1 | 2.07091876 |
| 14 | OBSCN | 2.02122802 |
| 15 | NTRK2 | 2.00187067 |
| 16 | PAK6 | 1.94792832 |
| 17 | MAP3K4 | 1.88980186 |
| 18 | FES | 1.77520036 |
| 19 | CASK | 1.74664387 |
| 20 | TAOK1 | 1.67073563 |
| 21 | CDK5 | 1.62606380 |
| 22 | ARAF | 1.62494003 |
| 23 | MAP3K13 | 1.61492955 |
| 24 | KSR1 | 1.55185623 |
| 25 | TNIK | 1.49028657 |
| 26 | MAPK12 | 1.48922923 |
| 27 | TYRO3 | 1.48327603 |
| 28 | MAP3K2 | 1.48164911 |
| 29 | CAMKK2 | 1.31238599 |
| 30 | DAPK1 | 1.26472251 |
| 31 | SIK2 | 1.24877928 |
| 32 | PIK3CA | 1.24702429 |
| 33 | LMTK2 | 1.23045728 |
| 34 | MAP2K7 | 1.21727636 |
| 35 | PRPF4B | 1.20269693 |
| 36 | PINK1 | 1.17048644 |
| 37 | STK38 | 1.14796468 |
| 38 | RAF1 | 1.10474323 |
| 39 | PRKCH | 1.10108974 |
| 40 | SGK494 | 1.08837010 |
| 41 | SGK223 | 1.08837010 |
| 42 | MAP2K4 | 1.04800779 |
| 43 | UHMK1 | 1.04652574 |
| 44 | PHKG2 | 1.01082477 |
| 45 | PHKG1 | 1.01082477 |
| 46 | RIPK1 | 0.97657882 |
| 47 | PKN1 | 0.97326914 |
| 48 | MARK2 | 0.94407499 |
| 49 | STK11 | 0.92943450 |
| 50 | ROCK2 | 0.91265070 |
| 51 | DMPK | 0.90094554 |
| 52 | PDPK1 | 0.86493560 |
| 53 | RET | 0.85629109 |
| 54 | PRKAA1 | 0.85181880 |
| 55 | CAMK1 | 0.84124362 |
| 56 | TRIB3 | 0.83578076 |
| 57 | CAMK2A | 0.82394042 |
| 58 | SGK3 | 0.81979218 |
| 59 | CDK15 | 0.80992118 |
| 60 | SGK1 | 0.80271047 |
| 61 | SGK2 | 0.79993459 |
| 62 | BMPR2 | 0.79950312 |
| 63 | PRKCG | 0.79657503 |
| 64 | CDK18 | 0.79515795 |
| 65 | CDK14 | 0.77720821 |
| 66 | CAMK2B | 0.77253679 |
| 67 | ALK | 0.77049222 |
| 68 | PDK1 | 0.76556457 |
| 69 | NEK1 | 0.76128389 |
| 70 | TIE1 | 0.75469702 |
| 71 | MAPK13 | 0.75049877 |
| 72 | MAP3K1 | 0.72978921 |
| 73 | GRK5 | 0.72248216 |
| 74 | MAPK4 | 0.71766064 |
| 75 | PTK2B | 0.69829651 |
| 76 | CDK11A | 0.69357763 |
| 77 | DYRK1A | 0.69100510 |
| 78 | NEK6 | 0.68698234 |
| 79 | WNK1 | 0.67836376 |
| 80 | TNK2 | 0.65403746 |
| 81 | LIMK1 | 0.65261238 |
| 82 | PRKAA2 | 0.63076242 |
| 83 | MAP3K5 | 0.62591400 |
| 84 | DAPK3 | 0.59385391 |
| 85 | EPHA3 | 0.59086985 |
| 86 | MAP3K6 | 0.59040012 |
| 87 | FYN | 0.58041598 |
| 88 | GRK7 | 0.57835832 |
| 89 | MAP2K1 | 0.57616816 |
| 90 | EPHB2 | 0.57438986 |
| 91 | RPS6KA3 | 0.57197570 |
| 92 | PAK3 | 0.56159264 |
| 93 | FGFR2 | 0.55970929 |
| 94 | PKN2 | 0.54884415 |
| 95 | PRKD2 | 0.54695826 |
| 96 | PRKACA | 0.54578110 |
| 97 | CAMK2D | 0.52827702 |
| 98 | RPS6KA2 | 0.52667087 |
| 99 | PRKG1 | 0.52186420 |
| 100 | CAMK4 | 0.51455495 |
| 101 | PRKCZ | 0.51292470 |
| 102 | MAPKAPK3 | 0.50819038 |
| 103 | CDC42BPA | 0.50113321 |
| 104 | CDK19 | 0.48713079 |
| 105 | BRSK1 | 0.47597866 |
| 106 | TESK1 | 0.47497988 |
| 107 | MAPK10 | 0.47330071 |
| 108 | OXSR1 | 0.46794052 |
| 109 | PDGFRA | 0.44435380 |
| 110 | STK39 | 0.44073737 |
| 111 | CAMK2G | 0.43882628 |
| 112 | PRKD1 | 0.43220439 |
| 113 | MAP3K12 | 0.42999491 |
| 114 | PRKCE | 0.40048161 |
| 115 | PLK2 | 0.38277922 |
| 116 | CSNK1G2 | 0.37291805 |
| 117 | MAP3K7 | 0.36741175 |
| 118 | DDR2 | 0.36098935 |
| 119 | MUSK | 0.35359181 |
| 120 | MAPK7 | 0.34732096 |
| 121 | LATS2 | 0.34518149 |
| 122 | PRKACG | 0.33172419 |
| 123 | PRKCB | 0.32929294 |
| 124 | MOS | 0.32722203 |
| 125 | ROCK1 | 0.32667646 |
| 126 | CAMK1G | 0.31773384 |
| 127 | ICK | 0.31585300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 3.69323177 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.83627671 |
| 3 | * Morphine addiction_Homo sapiens_hsa05032 | 2.75740978 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.65638246 |
| 5 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.63966776 |
| 6 | * GABAergic synapse_Homo sapiens_hsa04727 | 2.61890075 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.52903488 |
| 8 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.42224173 |
| 9 | * Amphetamine addiction_Homo sapiens_hsa05031 | 2.39115564 |
| 10 | * Cocaine addiction_Homo sapiens_hsa05030 | 2.28102402 |
| 11 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.27492690 |
| 12 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.23582497 |
| 13 | * Cholinergic synapse_Homo sapiens_hsa04725 | 2.12544105 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.98099059 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.94306382 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.94190944 |
| 17 | * Salivary secretion_Homo sapiens_hsa04970 | 1.88993443 |
| 18 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.83193300 |
| 19 | * Renin secretion_Homo sapiens_hsa04924 | 1.79111196 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.77816368 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.74915448 |
| 22 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.72298786 |
| 23 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.72201804 |
| 24 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.67492853 |
| 25 | * Insulin secretion_Homo sapiens_hsa04911 | 1.60667182 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.53700285 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.44597397 |
| 28 | * Gap junction_Homo sapiens_hsa04540 | 1.44555579 |
| 29 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.42992074 |
| 30 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.40475964 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.37118228 |
| 32 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.31417122 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.28980469 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.23152175 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19446269 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.19107269 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.18064101 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16824096 |
| 39 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.12697484 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08895858 |
| 41 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07556124 |
| 42 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01425473 |
| 43 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00389522 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99823552 |
| 45 | Axon guidance_Homo sapiens_hsa04360 | 0.97686274 |
| 46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97165328 |
| 47 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95071945 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.92967915 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.91492679 |
| 50 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.91320639 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.89794006 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89262762 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.89044547 |
| 54 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84935389 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.83972991 |
| 56 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83899813 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82541520 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.81833370 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 0.81477566 |
| 60 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.80390794 |
| 61 | * Melanogenesis_Homo sapiens_hsa04916 | 0.80385851 |
| 62 | * Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.78500776 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75912740 |
| 64 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73682628 |
| 65 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73613108 |
| 66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73169480 |
| 67 | * Alcoholism_Homo sapiens_hsa05034 | 0.72531828 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72510937 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.72371101 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71617920 |
| 71 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71478284 |
| 72 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.70580832 |
| 73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69183789 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69114700 |
| 75 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.68542205 |
| 76 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.67780833 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67021578 |
| 78 | * Oocyte meiosis_Homo sapiens_hsa04114 | 0.65227975 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64439901 |
| 80 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.63042328 |
| 81 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62005350 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61735879 |
| 83 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61313291 |
| 84 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59935787 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59634016 |
| 86 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58715725 |
| 87 | Focal adhesion_Homo sapiens_hsa04510 | 0.58407789 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.57444178 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57103889 |
| 90 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.56457139 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55725347 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53144620 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52052191 |
| 94 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.51583633 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.51501131 |
| 96 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51079120 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49940118 |
| 98 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49463132 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49260037 |
| 100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49231277 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48817689 |
| 102 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46466978 |
| 103 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46423777 |
| 104 | Alzheimers disease_Homo sapiens_hsa05010 | 0.45085973 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42565812 |
| 106 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42042350 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41269847 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39718503 |
| 109 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39571331 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.39243130 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.39232650 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39174860 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.38686917 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.38058772 |
| 115 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.37414767 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37382709 |
| 117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37246029 |
| 118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36916215 |
| 119 | Tight junction_Homo sapiens_hsa04530 | 0.36104939 |
| 120 | * Bile secretion_Homo sapiens_hsa04976 | 0.32660791 |
| 121 | * Platelet activation_Homo sapiens_hsa04611 | 0.31884575 |
| 122 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29462942 |
| 123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28934965 |
| 124 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28485986 |
| 125 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27078764 |

